Search results
Results From The WOW.Com Content Network
A lower state court placed an injunction on a 1928 pre-Roe ban in Texas on June 28; by July 1, the Texas Supreme Court reversed this order. [ 207 ] [ 208 ] Legal efforts to block a Wisconsin pre- Roe ban from being enforced were announced on June 28; [ 209 ] by June 30, Michigan's state supreme court had yet to react to Governor Gretchen ...
A Texas judge sided with anti-abortion activists to remove the government’s approval of a commonly used abortion drug. The Supreme Court has blocked that decision, for now Supreme Court delays ...
The Supreme Court said Wednesday it will consider whether to restrict access to a widely used abortion drug — even in states where the procedure is still allowed.
The Supreme Court hears arguments on whether to maintain access to abortion pill mifepristone as it weighs a high-stakes challenge to the FDA's drug approval process.
On remand, the Fifth Circuit (by a 2–1 vote) on January 17 certified to the Supreme Court of Texas the state-law question of whether any of the state defendants had enforcement authority regarding SB 8, second-guessing the 8–1 conclusion of the U.S. Supreme Court that the Texas Medical Board at least "appears" to have enforcement authority ...
West Virginia's primary abortion statute is a holdover from a Virginia law passed in 1848. [6] The statute reads: Any person who shall administer to, or cause to be taken by, a woman, any drug or other thing, or use any means, with intent to destroy her unborn child, or to produce abortion or miscarriage, and shall thereby destroy such child, or produce such abortion or miscarriage, shall be ...
A judge in Texas ruled Thursday that three other states can move ahead with their effort to roll back federal rules and make it harder for people across the U.S. to access the abortion drug mifepristone. The states of Idaho, Kansas and Missouri made the request in U.S. District Court in Amarillo, Texas.
The 5th US Circuit Court of Appeals threw out part of the ruling – saying Kacsmaryk was incorrect in blocking the drug’s approval in 2000 – but left in the injunction against FDA’s actions ...